SiPhox Health, a healthcare company leveraging silicon photonic chips to make diagnostics faster, smaller, and less expensive, is developing a home-based diagnostic solution that offers consumers lab-grade results for proteins and hormones in under five minutes.

The SiPhox Home, currently available for investigational use only, is designed to measure a range of immunoassays for key biomarkers of inflammation, metabolism, hormonal, and heart health in a single sample. The platform, unveiled at the recent CES show in Las Vegas, requires less than a drop of blood, delivers results in under five minutes and has been externally validated against traditional central lab methods.

“Silicon Photonics has revolutionized the way internet data is transmitted, creating the modern world of Zoom and constant connectivity,” says SiPhox co-founder Diedrik Vermeulen, “SiPhox has applied this powerful semiconductor platform to enable testing that is 100x smaller, faster, and cheaper than anything out there – without sacrificing any quality or accuracy.”

Note that the SiPhox Home has not been evaluated by the FDA and is only available for investigational use. SiPhox Health is backed by Khosla Ventures and Ycombinator.

Featured image: The SiPhox Home consumer blood testing platform. This device is available for investigational use only. Photo: SiPhox Health